Article
Valeant Rejected Takeda Bid
May 27, 2016.
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story here.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Videos
Related Content
